Position in ACHV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$54,833
-$22,429 QoQ
Shares Held
18,651
-0.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#51
of 81 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Diametric Capital, LP holds $50,198,214 across 62 Biotechnology names. ACHV ranks #54 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
6,801,788 | $26,322,919 | |
| 2 | ABEO |
Abeona Therapeutics Inc.
|
611,520 | $2,739,609 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
63,896 | $2,079,175 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
57,832 | $1,936,215 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,000 | $1,458,750 | |
| 6 | ENLV |
Enlivex Ltd.
|
1,483,178 | $1,379,355 | |
| 7 | ABVX |
Abivax S.A.
|
10,000 | $1,113,500 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
125,000 | $1,058,750 |
All Filings in ACHV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,833 | 18,651 | Shares | Defined | 2026-05-15 | |
| 2023-12-31 | $77,262 | 18,753 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $340,603 | 79,210 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $436,364 | 84,078 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $315,513 | 46,399 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $48,762 | 19,903 | Shares | Defined | 2023-03-29 | |
| 2022-09-30 | $114,378 | 34,660 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $95,194 | 19,507 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||